{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:49:08Z","timestamp":1791650948671,"version":"4.3.4"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00507256"],"award-info":[{"award-number":["RS-2024-00507256"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-KH127715"],"award-info":[{"award-number":["RS-2023-KH127715"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00437692"],"award-info":[{"award-number":["RS-2024-00437692"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2024-00439685"],"award-info":[{"award-number":["RS-2024-00439685"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["RS-2026-25505636"],"award-info":[{"award-number":["RS-2026-25505636"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["RS-2024-00440824"],"award-info":[{"award-number":["RS-2024-00440824"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.arr.2026.103349","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:31:52Z","timestamp":1788276712000},"page":"103349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The force-producing fraction: Muscle quality as a therapeutic target in sarcopenia and a design framework for trials that can test it"],"prefix":"10.1016","volume":"122","author":[{"given":"Ju Hun","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8693-9630","authenticated-orcid":false,"given":"Cheol Ryong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Myung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103349_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13395-016-0101-y","article-title":"Failed reinnervation in aging skeletal muscle","volume":"6","author":"Aare","year":"2016","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.arr.2026.103349_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101398","article-title":"Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: a new paradigm beyond sarcopenia","volume":"70","author":"Ahn","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103349_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s42255-019-0073-4","article-title":"The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans","volume":"1","author":"Andreux","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.arr.2026.103349_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/mus.26017","article-title":"CK-2127107 amplifies skeletal muscle response to nerve activation in humans","volume":"57","author":"Andrews","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arr.2026.103349_bib5","article-title":"argenx advances clinical development of ARGX-119 in congenital myasthenic syndromes","year":"2025","journal-title":"Press release"},{"key":"10.1016\/j.arr.2026.103349_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI190646","article-title":"Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition","volume":"136","author":"Arnold","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.arr.2026.103349_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature16932","article-title":"Naturally occurring p16Ink4a-positive cells shorten healthy lifespan","volume":"530","author":"Baker","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103349_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg1485","article-title":"Regeneration of neuromuscular synapses after acute and chronic denervation by inhibiting the gerozyme 15-prostaglandin dehydrogenase","volume":"15","author":"Bakooshli","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2026.103349_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaci.2019.11.032","article-title":"Inhibiting eicosanoid degradation exerts antifibrotic effects in a pulmonary fibrosis mouse model and human tissue","volume":"145","author":"B\u00e4rnthaler","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.arr.2026.103349_bib10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.arr.2026.103349_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103349_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group","volume":"14","author":"Bauer","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.arr.2026.103349_bib13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jamda.2015.05.021","article-title":"Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Bauer","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.arr.2026.103349_bib14","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/gerona\/glab175","article-title":"Reliability and minimal detectable change values for performance-based measures of physical functioning in the Canadian Longitudinal Study on Aging","volume":"76","author":"Beauchamp","year":"2021","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.arr.2026.103349_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12877-019-1234-8","article-title":"Norwegian reference values for the Short Physical Performance Battery (SPPB): the Troms\u00f8 Study","volume":"19","author":"Bergland","year":"2019","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.arr.2026.103349_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068788","article-title":"Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project)","volume":"377","author":"Bernabei","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.arr.2026.103349_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ijo.2013.158","article-title":"Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine","volume":"38","author":"Besse-Patin","year":"2014","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.arr.2026.103349_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.111161","article-title":"Muscle fiber capillarization is associated with various indices of skeletal muscle mass in healthy, older men","volume":"143","author":"Betz","year":"2021","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.arr.2026.103349_bib20","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/jgs.16372","article-title":"Sarcopenia definition: the position statements of the Sarcopenia Definition and Outcomes Consortium","volume":"68","author":"Bhasin","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2026.103349_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamainternmed.2015.7148","article-title":"Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial","volume":"176","author":"Bischoff-Ferrari","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.arr.2026.103349_bib22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.1144090","article-title":"Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis","volume":"317","author":"Brack","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103349_bib23","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1111\/cas.15495","article-title":"Tumor microenvironmental 15-PGDH depletion promotes fibrotic tumor formation and angiogenesis in pancreatic cancer","volume":"113","author":"Bu","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.arr.2026.103349_bib24","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1096\/fj.11-191262","article-title":"Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia","volume":"25","author":"B\u00fctikofer","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2026.103349_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103349_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12877-025-05897-7","article-title":"Probable and confirmed sarcopenia are still better predictors of disability than sarcopenic obesity following ESPEN\/EASO consensus steps","volume":"25","author":"Cavdar","year":"2025","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.arr.2026.103349_bib27","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/jgs.16517","article-title":"Putative cut-points in sarcopenia components and incident adverse health outcomes: an SDOC analysis","volume":"68","author":"Cawthon","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2026.103349_bib28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/gerona\/gly129","article-title":"Strong relation between muscle mass determined by D3-creatine dilution, physical performance, and incidence of falls and mobility limitations in a prospective cohort of older men","volume":"74","author":"Cawthon","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib29","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3945\/ajcn.112.037556","article-title":"Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis","volume":"96","author":"Cermak","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.arr.2026.103349_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature11438","article-title":"The aged niche disrupts muscle stem cell quiescence","volume":"490","author":"Chakkalakal","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103349_bib31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.arr.2026.103349_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102589","article-title":"Mechanisms of muscle cells alterations and regeneration decline during aging","volume":"102","author":"Chinvattanachot","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103349_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neurobiolaging.2021.01.012","article-title":"Voluntary wheel running with and without follistatin overexpression improves NMJ transmission but not motor unit loss in late life of C57BL\/6J mice","volume":"101","author":"Chugh","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2026.103349_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/japplphysiol.00455.2016","article-title":"Creatine (methyl-d3) dilution in urine for estimation of total body skeletal muscle mass: accuracy and variability vs. MRI and DXA","volume":"124","author":"Clark","year":"2018","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102662","article-title":"Why are we not exploring the potential of lower limb muscle power to identify people with sarcopenia?","volume":"104","author":"Coelho-Junior","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103349_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2026.103121","article-title":"When expert agreement replaces evidence: the rise of Delphi consensus in geriatrics","volume":"118","author":"Coelho-Junior","year":"2026","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103349_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101883","article-title":"An elusive consensus definition of sarcopenia impedes research and clinical treatment: a narrative review","volume":"86","author":"Coletta","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103349_bib38","doi-asserted-by":"crossref","first-page":"14930","DOI":"10.1021\/acs.jmedchem.1c01067","article-title":"Discovery of reldesemtiv, a fast skeletal muscle troponin activator for the treatment of impaired muscle function","volume":"64","author":"Collibee","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.arr.2026.103349_bib39","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fphys.2020.00963","article-title":"Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging","volume":"11","author":"Correa-de-Araujo","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib40","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209151","article-title":"Safety and efficacy of apitegromab in patients with spinal muscular atrophy types 2 and 3: the phase 2 TOPAZ study","volume":"102","author":"Crawford","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103349_bib41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1474-4422(25)00225-X","article-title":"Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial","volume":"24","author":"Crawford","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103349_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.arr.2026.103349_bib43","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","article-title":"Sarcopenia","volume":"393","author":"Cruz-Jentoft","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103349_bib44","series-title":"ClinicalTrials.gov identifier NCT03065959","article-title":"A study to assess the anti-fatigability effect of CK-2127107 in elderly male and female subjects with limitations in mobility","year":"2017"},{"key":"10.1016\/j.arr.2026.103349_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.arr.2026.103349_bib46","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s11357-023-00750-4","article-title":"Sex differences in skeletal muscle-aging trajectory: same processes, but with a different ranking","volume":"45","author":"de Jong","year":"2023","journal-title":"GeroScience"},{"key":"10.1016\/j.arr.2026.103349_bib47","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3945\/ajcn.2009.28047","article-title":"Longitudinal study of muscle strength, quality, and adipose tissue infiltration","volume":"90","author":"Delmonico","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.arr.2026.103349_bib48","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrrheum.2017.60","article-title":"Epidemiology of sarcopenia and insight into possible therapeutic targets","volume":"13","author":"Dennison","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.arr.2026.103349_bib49","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","article-title":"International Clinical Practice Guidelines for Sarcopenia (ICFSR): screening, diagnosis and management","volume":"22","author":"Dent","year":"2018","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.arr.2026.103349_bib50","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jn\/nxy091","article-title":"Leucine, not total protein, content of a supplement is the primary determinant of muscle protein anabolic responses in healthy older women","volume":"148","author":"Devries","year":"2018","journal-title":"J. Nutr."},{"key":"10.1016\/j.arr.2026.103349_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.arr.2026.103349_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113637","article-title":"Grip strength across the life course: normative data from twelve British studies","volume":"9","author":"Dodds","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2026.103349_bib53","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1113\/JP278752","article-title":"Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men","volume":"598","author":"Dollerup","year":"2020","journal-title":"J. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib54","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.16042","article-title":"The effects of myosteatosis on skeletal muscle function in older adults","volume":"12","author":"Dondero","year":"2024","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.arr.2026.103349_bib55","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.clnu.2021.11.014","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"41","author":"Donini","year":"2022","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.arr.2026.103349_bib56","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s11357-022-00542-2","article-title":"Senolytic treatment rescues blunted muscle hypertrophy in old mice","volume":"44","author":"Dungan","year":"2022","journal-title":"GeroScience"},{"key":"10.1016\/j.arr.2026.103349_bib57","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","article-title":"Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures","volume":"28","author":"Elhassan","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2026.103349_bib58","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103349_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111595","article-title":"Skeletal muscle aging, cellular senescence, and senotherapeutics: current knowledge and future directions","volume":"200","author":"Englund","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.arr.2026.103349_bib60","article-title":"Epirium Bio announces positive Type C (end-of-Phase 1) meeting with FDA supporting advancement of MF-300 to a Phase 2b clinical trial in sarcopenia","year":"2026","journal-title":"Press release"},{"key":"10.1016\/j.arr.2026.103349_bib61","article-title":"Epirium Bio announces follow-on Phase 1 results in older adult participants for MF-300, a first-in-class, oral 15-PGDH enzyme inhibitor, for the treatment of sarcopenia","year":"2026","journal-title":"Press release"},{"key":"10.1016\/j.arr.2026.103349_bib62","article-title":"Epirium Bio to present new MF-300 clinical and translational data at the Intrinsic Capacity, Frailty and Sarcopenia Research Conference 2026","year":"2026","journal-title":"Press release"},{"key":"10.1016\/j.arr.2026.103349_bib63","article-title":"Phase 1 study of single and multiple ascending dosing administration of MF-300 in healthy participants","year":"2026","journal-title":"ClinicalTrials.gov identifier NCT07613684."},{"key":"10.1016\/j.arr.2026.103349_bib64","series-title":"Opinions and letters of support on the qualification of novel methodologies for medicine development","year":"2026"},{"key":"10.1016\/j.arr.2026.103349_bib65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcsm.12390","article-title":"D3-creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass","volume":"10","author":"Evans","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.arr.2026.103349_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae113","article-title":"A systematic review of the psychometric properties of physical performance tests for sarcopenia in community-dwelling older adults","author":"Exter","year":"2024","journal-title":"Age Ageing 53 afae113"},{"key":"10.1016\/j.arr.2026.103349_bib67","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1038\/s41467-025-60586-8","article-title":"Bioactive lipid mediator class switching regulates myogenic cell progression and muscle regeneration","volume":"16","author":"Fabre","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103349_bib68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.arr.2026.103349_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13750","article-title":"BIO101 in sarcopenic seniors at risk of mobility disability: results of a double-blind randomised interventional phase 2b trial","volume":"16","author":"Fielding","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.arr.2026.103349_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008481","article-title":"Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)","volume":"6","author":"Fink","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2026.103349_bib71","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1038\/s41467-025-59380-3","article-title":"GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial","volume":"16","author":"Gonzalez Trotter","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103349_bib72","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1152\/jappl.2001.90.6.2157","article-title":"Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study","volume":"90","author":"Goodpaster","year":"2001","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib73","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1152\/japplphysiol.90425.2008","article-title":"Effects of physical activity on strength and skeletal muscle fat infiltration in older adults: a randomized controlled trial","volume":"105","author":"Goodpaster","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib74","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1152\/jappl.2000.89.1.104","article-title":"Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content","volume":"89","author":"Goodpaster","year":"2000","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib75","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","article-title":"The loss of skeletal muscle strength, mass, and quality in older adults: the Health, Aging and Body Composition Study","volume":"61","author":"Goodpaster","year":"2006","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib76","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103349_bib77","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1152\/japplphysiol.00919.2013","article-title":"Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes","volume":"116","author":"Groen","year":"2014","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib78","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.20061617","article-title":"Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors","volume":"204","author":"Gross","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2026.103349_bib79","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14283\/jfa.2019.33","article-title":"Clinically meaningful change for physical performance: perspectives of the ICFSR Task Force","volume":"9","author":"Guralnik","year":"2020","journal-title":"J. Frailty Aging"},{"key":"10.1016\/j.arr.2026.103349_bib80","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/mus.24239","article-title":"Tirasemtiv amplifies skeletal muscle response to nerve activation in humans","volume":"50","author":"Hansen","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.arr.2026.103349_bib81","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41073-016-0007-6","article-title":"Sex and gender equity in research: rationale for the SAGER guidelines and recommended use","volume":"1","author":"Heidari","year":"2016","journal-title":"Res. Integr. Peer Rev."},{"key":"10.1016\/j.arr.2026.103349_bib82","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1113\/JP270561","article-title":"Innervation and neuromuscular control in ageing skeletal muscle","volume":"594","author":"Hepple","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib83","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41591-026-04204-0","article-title":"Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial","volume":"32","author":"Heymsfield","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103349_bib84","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: a phase 2 randomized clinical trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.arr.2026.103349_bib85","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2026.103349_bib86","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/S2666-7568(21)00084-2","article-title":"Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a\/b trial","volume":"2","author":"Hofbauer","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.arr.2026.103349_bib87","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1210\/jc.2018-01734","article-title":"The muscle protein synthetic response to whey protein ingestion is greater in middle-aged women compared with men","volume":"104","author":"Horstman","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2026.103349_bib88","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40279-020-01388-4","article-title":"Sex differences in adaptations in muscle strength and size following resistance training in older adults: a systematic review and meta-analysis","volume":"51","author":"Jones","year":"2021","journal-title":"Sports Med."},{"key":"10.1016\/j.arr.2026.103349_bib89","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2026.103349_bib90","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12880","article-title":"Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults","volume":"18","author":"Konopka","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2026.103349_bib91","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12603-009-0104-z","article-title":"What is a meaningful change in physical performance? Findings from a clinical trial in older adults (the LIFE-P study)","volume":"13","author":"Kwon","year":"2009","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.arr.2026.103349_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136217","article-title":"Increased stiffness in aged skeletal muscle impairs muscle progenitor cell proliferative activity","volume":"10","author":"Lacraz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2026.103349_bib93","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1152\/physrev.00061.2017","article-title":"Sarcopenia: aging-related loss of muscle mass and function","volume":"99","author":"Larsson","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.arr.2026.103349_bib94","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44279","article-title":"Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial","volume":"5","author":"Liu","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.arr.2026.103349_bib95","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.maturitas.2017.04.007","article-title":"Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis","volume":"103","author":"Liu","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.arr.2026.103349_bib96","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1152\/japplphysiol.00396.2015","article-title":"Prostaglandin E2\/cyclooxygenase pathway in human skeletal muscle: influence of muscle fiber type and age","volume":"120","author":"Liu","year":"2016","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102267","article-title":"Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia","volume":"96","author":"Livshits","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103349_bib98","first-page":"471","article-title":"Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition","volume":"7","author":"MacDonald","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.arr.2026.103349_bib99","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021013118","article-title":"FGF-2-dependent signaling activated in aged human skeletal muscle promotes intramuscular adipogenesis","volume":"118","author":"Mathes","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2026.103349_bib100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2046-2395-3-9","article-title":"It is not just muscle mass: a review of muscle quality, composition and metabolism during ageing as determinants of muscle function and mobility in later life","volume":"3","author":"McGregor","year":"2014","journal-title":"Longev. Healthspan"},{"key":"10.1016\/j.arr.2026.103349_bib101","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/gerona\/gly040","article-title":"The contributions of fiber atrophy, fiber loss, in situ specific force, and voluntary activation to weakness in sarcopenia","volume":"73","author":"McPhee","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib102","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103349_bib103","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afae055","article-title":"Measurement properties of the usual and fast gait speed tests in community-dwelling older adults: a COSMIN-based systematic review","volume":"53","author":"Mehdipour","year":"2024","journal-title":"Age Ageing"},{"key":"10.1016\/j.arr.2026.103349_bib104","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/mt.2014.200","article-title":"A phase 1\/2a follistatin gene therapy trial for Becker muscular dystrophy","volume":"23","author":"Mendell","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.arr.2026.103349_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnu.2026.106675","article-title":"Current application and future directions for the sarcopenic obesity Global Leadership Initiative (SOGLI) diagnostic algorithm","volume":"62","author":"Minnetti","year":"2026","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.arr.2026.103349_bib106","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1080\/15384101.2015.1026520","article-title":"Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation","volume":"14","author":"Mo","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.arr.2026.103349_bib107","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41586-022-05535-x","article-title":"Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration","volume":"613","author":"Moiseeva","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103349_bib108","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/gerona\/glu103","article-title":"Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men","volume":"70","author":"Moore","year":"2015","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib109","doi-asserted-by":"crossref","first-page":"12098","DOI":"10.1073\/pnas.0603235103","article-title":"15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis","volume":"103","author":"Myung","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2026.103349_bib110","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2606533123","article-title":"15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss","volume":"123","author":"Nalbandian","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2026.103349_bib111","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2008.06.051","article-title":"AMPK and PPARdelta agonists are exercise mimetics","volume":"134","author":"Narkar","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103349_bib112","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-149-9-200811040-00003","article-title":"Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial","volume":"149","author":"Nass","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.arr.2026.103349_bib113","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/gerona\/61.1.72","article-title":"Strength, but not muscle mass, is associated with mortality in the Health, Aging and Body Composition Study cohort","volume":"61","author":"Newman","year":"2006","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102587","article-title":"Sarcopenia and the biological determinants of aging: a narrative review from a geroscience perspective","volume":"103","author":"Nunes-Pinto","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103349_bib115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ajpath.2023.01.009","article-title":"Circulating alpha-Klotho counteracts transforming growth factor-beta-induced sarcopenia","volume":"193","author":"Ohsawa","year":"2023","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2026.103349_bib116","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12877-017-0514-4","article-title":"Reliability of the Norwegian version of the short physical performance battery in older people with and without dementia","volume":"17","author":"Olsen","year":"2017","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.arr.2026.103349_bib117","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14029","article-title":"Effect of canakinumab on frailty: a post hoc analysis of the CANTOS trial","volume":"23","author":"Orkaby","year":"2024","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2026.103349_bib118","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/gerona\/glaa064","article-title":"The importance of muscle versus fat mass in sarcopenic obesity: a re-evaluation using D3-creatine muscle mass versus DXA lean mass measurements","volume":"75","author":"Orwoll","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib119","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/gerona\/gly277","article-title":"Effect of losartan and fish oil on plasma IL-6 and mobility in older persons. The ENRGISE pilot randomized clinical trial","volume":"74","author":"Pahor","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib120","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1001\/jama.2014.5616","article-title":"Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial","volume":"311","author":"Pahor","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2026.103349_bib121","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8059","article-title":"Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength","volume":"371","author":"Palla","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103349_bib122","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12603-013-0335-x","article-title":"A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia","volume":"17","author":"Papanicolaou","year":"2013","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.arr.2026.103349_bib123","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1532-5415.2006.00701.x","article-title":"Meaningful change and responsiveness in common physical performance measures in older adults","volume":"54","author":"Perera","year":"2006","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2026.103349_bib124","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.arr.2026.103349_bib125","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.arr.2010.03.004","article-title":"Resistance exercise for muscular strength in older adults: a meta-analysis","volume":"9","author":"Peterson","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103349_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102213","article-title":"Pharmacological interventions in human aging","volume":"95","author":"Petr","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103349_bib127","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10522-015-9627-3","article-title":"Age-dependent motor unit remodelling in human limb muscles","volume":"17","author":"Piasecki","year":"2016","journal-title":"Biogerontology"},{"key":"10.1016\/j.arr.2026.103349_bib128","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1113\/JP275520","article-title":"Failure to expand the motor unit size to compensate for declining motor unit numbers distinguishes sarcopenic from non-sarcopenic older men","volume":"596","author":"Piasecki","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib129","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3389\/fphys.2019.00449","article-title":"Long-term endurance and power training may facilitate motor unit size expansion to compensate for declining motor unit numbers in older age","volume":"10","author":"Piasecki","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib130","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2213-8587(24)00272-9","article-title":"Muscle matters: the effects of medically induced weight loss on skeletal muscle","volume":"12","author":"Prado","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.arr.2026.103349_bib131","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/s41591-026-04440-4","article-title":"Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"32","author":"Pratley","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103349_bib132","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/gerona\/glw017","article-title":"Sarcopenia is associated with lower skeletal muscle capillarization and exercise capacity in older adults","volume":"71","author":"Prior","year":"2016","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib133","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s40520-020-01663-4","article-title":"Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults","volume":"33","author":"Reginster","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.arr.2026.103349_bib134","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41467-017-01131-0","article-title":"Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy","volume":"8","author":"Reza","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103349_bib135","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0021-9258(19)68084-1","article-title":"Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle","volume":"257","author":"Rodemann","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103349_bib136","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ymthe.2025.02.030","article-title":"Long-term effects of s-KL treatment in wild-type mice: enhancing longevity, physical well-being, and neurological resilience","volume":"33","author":"Roig-Soriano","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.arr.2026.103349_bib137","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jgs.14927","article-title":"Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study","volume":"65","author":"Rooks","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2026.103349_bib138","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.20836","article-title":"Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial","volume":"3","author":"Rooks","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.arr.2026.103349_bib139","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13293-019-0257-3","article-title":"Muscle metabolism and atrophy: let's talk about sex","volume":"10","author":"Rosa-Caldwell","year":"2019","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.arr.2026.103349_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253849","article-title":"vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial","volume":"16","author":"Roshanravan","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2026.103349_bib141","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.117.10787","article-title":"Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults","volume":"71","author":"Rossman","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.arr.2026.103349_bib142","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCRESAHA.122.321475","article-title":"Inhibition of eicosanoid degradation mitigates fibrosis of the heart","volume":"132","author":"Rubino","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103349_bib143","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjp.0706669","article-title":"Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses","volume":"147","author":"Ryall","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2026.103349_bib144","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nm.4132","article-title":"Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents","volume":"22","author":"Ryu","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103349_bib145","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1038\/s41467-018-07253-3","article-title":"Age-related declines in alpha-Klotho drive progenitor cell mitochondrial dysfunction and impaired muscle regeneration","volume":"9","author":"Sahu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103349_bib146","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12603-022-1800-1","article-title":"Circulating levels of apelin, GDF-15 and sarcopenia: lack of association in the MAPT study","volume":"26","author":"S\u00e1nchez-S\u00e1nchez","year":"2022","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.arr.2026.103349_bib147","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/gerona\/glp097","article-title":"Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength","volume":"64","author":"Schaap","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib148","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00421-011-2072-3","article-title":"Relationship of low plasma klotho with poor grip strength in older community-dwelling adults: the InCHIANTI study","volume":"112","author":"Semba","year":"2012","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib149","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.3390\/ijms251910273","article-title":"Taldefgrobep alfa and the phase 3 RESILIENT trial in spinal muscular atrophy","volume":"25","author":"Servais","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/jamaneurol.2025.0241","article-title":"Reldesemtiv in amyotrophic lateral sclerosis: results from the COURAGE-ALS randomized clinical trial","volume":"82","author":"Shefner","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103349_bib151","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.0501559102","article-title":"Decline in skeletal muscle mitochondrial function with aging in humans","volume":"102","author":"Short","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2026.103349_bib152","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.2106\/JBJS.24.00866","article-title":"PGE2 ameliorates aging-aggravated rotator cuff muscle atrophy","volume":"107","author":"Shu","year":"2025","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.arr.2026.103349_bib153","doi-asserted-by":"crossref","first-page":"M644","DOI":"10.1093\/gerona\/56.10.M644","article-title":"Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study","volume":"56","author":"Simonsick","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib154","article-title":"Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults","volume":"3","author":"Singh","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.arr.2026.103349_bib155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk9109","article-title":"The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis","volume":"16","author":"Skov","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2026.103349_bib156","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2042-6410-3-11","article-title":"Sexually dimorphic effect of aging on skeletal muscle protein synthesis","volume":"3","author":"Smith","year":"2012","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.arr.2026.103349_bib157","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jcsm.12137","article-title":"Muscle fibre capillarization is a critical factor in muscle fibre hypertrophy during resistance exercise training in older men","volume":"8","author":"Snijders","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.arr.2026.103349_bib158","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103349_bib159","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature13013","article-title":"Geriatric muscle stem cells switch reversible quiescence into senescence","volume":"506","author":"Sousa-Victor","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103349_bib160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.plefa.2013.02.004","article-title":"Prostaglandin E2 induces transcription of skeletal muscle mass regulators interleukin-6 and muscle RING finger-1 in humans","volume":"88","author":"Standley","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.arr.2026.103349_bib161","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/acel.12578","article-title":"Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion","volume":"16","author":"Stearns-Reider","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2026.103349_bib162","first-page":"583","article-title":"Effects of testosterone supplementation for 3 years on muscle performance and physical function in older men","volume":"102","author":"Storer","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2026.103349_bib163","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1348212","article-title":"The effects of beta-hydroxy-beta-methylbutyrate or HMB-rich nutritional supplements on sarcopenia patients: a systematic review and meta-analysis","volume":"11","author":"Su","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.arr.2026.103349_bib165","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1503\/cmaj.061339","article-title":"Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial","volume":"177","author":"Sumukadas","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.arr.2026.103349_bib166","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.arr.2026.103349_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.673404","article-title":"Evolving roles of muscle-resident fibro-adipogenic progenitors in health, regeneration, neuromuscular disorders, and aging","volume":"12","author":"Theret","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102433","article-title":"Rycal S48168 (ARM210) for RYR1-related myopathies: a phase one, open-label, dose-escalation trial","volume":"68","author":"Todd","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.arr.2026.103349_bib169","doi-asserted-by":"crossref","first-page":"R655","DOI":"10.1152\/ajpregu.00611.2010","article-title":"Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults","volume":"300","author":"Trappe","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.arr.2026.103349_bib170","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/gerona\/glr100","article-title":"Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation","volume":"66","author":"Travison","year":"2011","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib171","unstructured":"U.S. Food and Drug Administration, 2017. The voice of the patient: sarcopenia. Patient-Focused Drug Development Initiative Report. Center for Drug Evaluation and Research, Silver Spring, MD."},{"key":"10.1016\/j.arr.2026.103349_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101385","article-title":"DOK7 gene therapy enhances neuromuscular junction innervation and motor function in aged mice","volume":"23","author":"Ueta","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.arr.2026.103349_bib173","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ncb2014","article-title":"Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle","volume":"12","author":"Uezumi","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.arr.2026.103349_bib174","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1242\/jcs.086629","article-title":"Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle","volume":"124","author":"Uezumi","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.arr.2026.103349_bib175","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ng.153","article-title":"Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy","volume":"40","author":"Uppal","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.arr.2026.103349_bib176","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.1002220107","article-title":"Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise","volume":"107","author":"Valdez","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2026.103349_bib177","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado7189","article-title":"ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome","volume":"16","author":"Vanhauwaert","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2026.103349_bib178","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/jcsm.13502","article-title":"Sarcopenic obesity and health outcomes: an umbrella review of systematic reviews with meta-analysis","volume":"15","author":"Veronese","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.arr.2026.103349_bib179","article-title":"Veru announces positive topline data from Phase 2b QUALITY clinical study: enobosarm preserved lean mass in patients receiving WEGOVY (semaglutide) for weight reduction","year":"2025","journal-title":"Press release"},{"key":"10.1016\/j.arr.2026.103349_bib180","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41591-018-0131-6","article-title":"The exerkine apelin reverses age-associated sarcopenia","volume":"24","author":"Vinel","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103349_bib181","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/gerona\/60.3.324","article-title":"Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons","volume":"60","author":"Visser","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib182","doi-asserted-by":"crossref","first-page":"M326","DOI":"10.1093\/gerona\/57.5.M326","article-title":"Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC study","volume":"57","author":"Visser","year":"2002","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib183","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nmd.2020.05.002","article-title":"Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy","volume":"30","author":"Wagner","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.arr.2026.103349_bib184","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers","volume":"12","author":"Wakabayashi","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.arr.2026.103349_bib185","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13039","article-title":"Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: a randomized, double-blind, placebo-controlled, multicenter trial: the MASTERS trial","volume":"18","author":"Walton","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2026.103349_bib186","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.arr.2026.103349_bib187","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.stem.2025.05.012","article-title":"Multiomic profiling reveals that prostaglandin E2 reverses aged muscle stem cell dysfunction, leading to increased regeneration and strength","volume":"32","author":"Wang","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.arr.2026.103349_bib188","doi-asserted-by":"crossref","first-page":"14507","DOI":"10.1073\/pnas.0606586103","article-title":"Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2026.103349_bib189","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/gerona\/glab111","article-title":"Effect of aerobic or resistance exercise, or both, on intermuscular and visceral fat and physical and metabolic function in older adults with obesity while dieting","volume":"77","author":"Waters","year":"2022","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.arr.2026.103349_bib190","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10557-022-07328-w","article-title":"A first-in-human study of AMG 986, a novel apelin receptor agonist, in healthy subjects and heart failure patients","volume":"37","author":"Winkle","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.arr.2026.103349_bib191","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.aab2674","article-title":"Sestrin2 is a leucine sensor for the mTORC1 pathway","volume":"351","author":"Wolfson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103349_bib192","first-page":"1","article-title":"A phase 2 randomized study investigating the efficacy and safety of myostatin antibody LY2495655 versus placebo in patients undergoing elective total hip arthroplasty","author":"Woodhouse","year":"2016","journal-title":"J. Frailty Aging 5"},{"key":"10.1016\/j.arr.2026.103349_bib193","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.1073\/pnas.0406142101","article-title":"15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers","volume":"101","author":"Yan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2026.103349_bib194","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.abe9985","article-title":"Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women","volume":"372","author":"Yoshino","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103349_bib195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","article-title":"Fisetin is a senotherapeutic that extends health and lifespan","volume":"36","author":"Yousefzadeh","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2026.103349_bib196","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103349_bib197","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa2340","article-title":"Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration","volume":"348","author":"Zhang","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103349_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2025.112710","article-title":"Inhibition of 15-PGDH by SW033291 ameliorates age-related heart failure in mice","volume":"202","author":"Zhang","year":"2025","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.arr.2026.103349_bib199","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.1523\/JNEUROSCI.0860-18.2018","article-title":"Sarcoglycan alpha mitigates neuromuscular junction decline in aged mice by stabilizing LRP4","volume":"38","author":"Zhao","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103349_bib200","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles' heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:52:35Z","timestamp":1791647555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726003417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":200,"alternative-id":["S1568163726003417"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103349","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The force-producing fraction: Muscle quality as a therapeutic target in sarcopenia and a design framework for trials that can test it","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103349"}}